This bill, titled the End Tuberculosis Now Act of 2026, changes section 104B of the Foreign Assistance Act to direct and authorize U.S. foreign assistance to prevent, diagnose, treat, and help eliminate tuberculosis (TB) worldwide. It lists findings about the global TB burden, sets policy goals, and says U.S. aid should focus on active case finding, quality diagnosis and treatment for all forms of TB (including drug-resistant TB and latent TB), patient support, infection control in congregate settings, strengthening lab and health systems, research and development (including vaccines and new diagnostics), and public–private partnerships. The bill requires the President to establish specific 2027–2030 goals (including numeric targets for reductions in TB incidence and mortality, diagnosis and treatment coverage, and providing 30 million people preventive treatment), prioritize high-burden countries, and coordinate with international and nongovernmental partners.
No publicly available information on total or specific funding levels is included in the bill text. The bill "authorizes" the President to furnish assistance but does not set dollar amounts or appropriations. It requires annual reports that must include breakdowns of expenditures for patient care, drugs, training, procurement, and related activities. The amendment sunsets on January 1, 2033.
The bill’s findings and policy text state that TB remains a serious international health threat, that additional tools and resources are needed, and that well-resourced TB programs can help prevent and respond to future airborne respiratory pandemics. Supporters in the bill prioritize expanding diagnosis and treatment, preventing new infections, strengthening health systems and labs, promoting research and vaccines, and working with partners including the private sector to reach high-risk and underserved populations.
No publicly available information.